A comprehensive approach to the spectrum of abnormal pubertal development

Adolescent Medicine: State of the Art Reviews

Volumn 23, Issue 1, 2012, Pages 1-14

  Appelbaum, Heather ^a   Malhotra, Shilpa ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN;

ADOLESCENT; ADOLESCENT DEVELOPMENT; DELAYED PUBERTY; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPOGONADISM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRECOCIOUS PUBERTY; PUBERTY; REVIEW;

ADOLESCENT; ADOLESCENT DEVELOPMENT; DIAGNOSIS, DIFFERENTIAL; GONADOTROPINS; HUMANS; HYPOGONADISM; PUBERTY; PUBERTY, DELAYED; PUBERTY, PRECOCIOUS;

EID: 84864099114     PISSN: 19344287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Susman EJ, Houts RM, Steinberg L, et al. Longitudinal development of secondary sexual characteristics in girls and boys between ages 9 Vt and 15 Vi years. Arch Pediatr Adolesc Med. 2010;164 (2):164-173
2. Kaplowitz P. Update on precocious puberty: girls are showing signs of puberty earlier, but most do not require treatment. Adv Pediatr. 2011:58:243-258
3. Abassi V. Growth and normal puberty. Pediatrics. 1998:102:
4. Biro FM, Galvez MP, Greenspan LC. Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics. 2010;126(3):583-590
5. Hermman-Giddens ME, Slora EJ, Wasserman RC. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99(4):505-512
6. Wu T, Mendola P, Buck GM. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics. 2002:110(4):752-757
7. Buck Louis GM, Gray LE, Marcus M. Environmental factors and puberty timing: expert panel research needs. Pediatrics. 2008;121:192-207
8. Burt Solorzano CM, McCartney CR. Obesity and the pubertal transition in girls and boys. Reproduction. 2010;140{3}:399-410
9. Donato J, Cravo R, Frazao R. Hypothalamic sites of leptin action linking metabolism and reproduction. Neuroendocrinology. 2011;93:9-18
10. Quennell JH, Mulligan AC, Tups A. Leptin indirectly regulates gonadotropin-releasing hormone neuronal function. Neuroendocrinology. 2009;150(6):2805-28012
11. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 1996;12:318-320
12. Ibanez L, Vails C, Ong K. Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low birth weight girls with early-normal onset of puberty. / Clin Endocrinol Metab. 2006;91(6):2068-2073
13. Idkowaik J, Lavery GG, Dir V. Premature adrenarche: novel lessons from early onset androgen excess. Eur f Endocrinol. 2011;165:189-207
14. Ahmed ML, Ong KK, Dunger DB. Childhood obesity and the timing of puberty. Trends Endocrinol Metab. 2009;20:237-242
15. McLachlan JA, Simpson I, Martin M. Endocrine disruptors and female reproductive health. Best Pract Res Clin Endocrinol Metab. 2006;20:63-75
16. Jacobson-Dickeran I, Le MM. Influence of endocrine disruptors on pubertal timing. Curr Opin Endocrinol Diabetes Obes. 2009;16:25-30
17. Ozen S, Darcan S. Effects of environmental endocrine disruptors on pubertal development. / Clin Res Pediatr Endocrinol. 201 l;3(l):l-6
18. Nebesio TD, Pescovitz OH. Historical perspectives: endocrine disruptors and the timing of puberty. Endocrinology. 2005;15(l):44-48
19. Carel JC, Eugster E, Rogol A. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123(4):752-762
20. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics. 2003;111:47
21. Teles MG, Bianco SD, Brito VN. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med. 2008;358(7):709-715
22. Sills ES, Walsh AP. The GPR54-Kisspeptin complex in reproductive biology: neuroendocrine significance and implications for ovulation induction and contraception. Neuro Endocrinol Lett. 2008;29(6):846-851
23. Pineda R, Garcia-Galiano D, Roseweir A. Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology. 2010;151(2):722-730
24. Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009;123(1):84-88
25. Van Weissenbruch MM. Premature adrenarche, polycystic ovary syndrome and intrauterine growth retardation: does a relationship exist? Curr Opin Endocrinol Diabetes Obes. 2007;14(l):35-40
26. DeVries L, Guz-Mark A, Lazar L Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty. / Pediatr. 2010;156(3):466-471
27. Kushnir MM, Rockwood AL, Roberts WL. Development and performance evaluation of tandem mass spectrometry assay for four androgen steroids. Clin Chem. 52:159-167
28. Palmert MFR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls; initial presentation in long-term follow up of 20 untreated patients. / Clin Endocrinol Metab. 1999;84(2):415-423
29. Lazar L, Kauli R, Pertzelan A. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab. 2002;87(5):2090-2094
30. Eugster EA. Aromatase inhibitors in precocious puberty: rationale and experience to date. Treat Endocrinol. 2004;3(3):141-151
31. Acharya SV, Gopal RA, George J. Utility of single luteinizing hormone determination 3h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty. Pituitary. 2009;12:335-338
32. Sedlemeyer IL, Palmert MR. Delayed puberty: analysis of a case series from an academic center. J Clin Endocrinol Metab. 2002;87:1613
33. Shatavi SV, Llanes G, Luborsky J. Association of unexplained infertility with gonadotropin and ovarian antibodies. Am J Reprod Immunol. 2006;56(5):286-291
34. Meyer WR, Lavy G, DecCherney AH. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990;75:795-799
35. Luborsky JL, Visintinl, Boyers S. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. / Clin Endocrinol Metab. 1990;70:69-75
36. Acerini CL, Tasker, RC, Bellone S. Hypopituitarism in childhood and adolescence following traumatic brain injury: the case for prospective endocrine investigation. Eur J Endocrinol. 2006;155:663-669
37. Caronia LM, Martin C, Welt, C. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011 ;364(3):215-225
38. Welt CK, Chan JL, Bullen J. Recombinant human leptin in women with hypothalamic amenorrhea. NEnglJ Med. 2004;351:987-997
39. Georgopoulos NA. Growth in athletes. Ann NY Acad Sei. 2010;1205:39-44
40. Edozien LC. Mind over matter: psychological factors and the menstrual cycle. Curr Opin Obstet Gynecol. 2006;18:452-456
41. Emans SJ. Delayed Puberty. In: Emans SJ, Läufer MR, Goldstein DP. Pediatric and Adolescent Gynecology. 5th ed. Baltimore, MD: Lippincott Williams and Wilkins; 2005:181-213
42. Benjamin I, Block RE. Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis. Obstet Gynecol. 1977;50:136